Astrana Health (ASTH) Cash from Investing Activities (2010 - 2026)

Astrana Health has disclosed Cash from Investing Activities across 17 years of filings, most recently posting -$2.8 million for Q1 2026.

• Cash from Investing Activities for Q1 2026 came in at -$2.8 million, down 18.8% year-over-year; the trailing twelve-month figure through Mar 2026 was -$539.4 million (down 335.92% YoY), and the FY2025 annual result was -$539.0 million, down 180.15% from the prior year.
• Cash from Investing Activities came in at -$2.8 million for Q1 2026 at Astrana Health, down from -$1.1 million in the prior quarter.
• In the past five years, Cash from Investing Activities ranged from a high of $13.2 million in Q4 2022 to a low of -$534.5 million in Q3 2025.
• The 5-year median for Cash from Investing Activities is -$8.1 million (2024), against an average of -$47.5 million.
• Across the five-year window, Cash from Investing Activities surged 171.44% in 2022 and plunged 6492.71% in 2025, its largest moves.
• Astrana Health's Cash from Investing Activities stood at $13.2 million in 2022, then slumped by 186.56% to -$11.4 million in 2023, then sank by 191.63% to -$33.3 million in 2024, then jumped by 96.83% to -$1.1 million in 2025, then tumbled by 169.06% to -$2.8 million in 2026.
• The last three Cash from Investing Activities figures came in at -$2.8 million (Q1 2026), -$1.1 million (Q4 2025), and -$534.5 million (Q3 2025), per Business Quant data.